AITX's RAD Dominates ISC West with Major Awards and Surge in Enterprise Leads
RAD Secures Over 300 Qualified Leads at ISC West 2025
Detroit, Michigan--(Newsfile Corp. - April 7, 2025) - Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (OTC Pink: AITX) (the "Company"), achieved a major milestone at ISC West 2025, the premier event for security professionals. RAD earned both the Best in Threat Detection and Response Solutions award and the prestigious Judges' Choice Award at the SIA New Product Showcase, with its SARA™ (Speaking Autonomous Responsive Agent) recognized as the standout innovation of the entire show.
Steve Reinharz, CEO/CTO of AITX and RAD, holds the SIA Judges' Choice Award earned by SARA, the AI Security Agent, during ISC West 2025, presented in the SARA Experience Zone at the RAD booth.
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/5243/247532_c97eb4e1b4ee683a_001full.jpg
These accolades reflect RAD's continued leadership in redefining physical security through artificial intelligence, robotics, and automation.
Beyond the awards, RAD connected with over 300 new prospects at the event, each verified and requesting follow-up. Nearly 50 of these prospects represent Fortune 1000 organizations, including six Fortune 50 companies not currently doing business with RAD. The volume and caliber of interest signal a rapid expansion of RAD's visibility and appeal across enterprise and institutional markets.
Widespread Industry Engagement
RAD's powerful lineup of solutions, including ROAMEO™, RIO™, AVA™, SARA, ROSA™, and its Firearm Detection analytic, sparked compelling conversations across numerous sectors:
Enterprise & Corporate Facilities: Multiple global organizations expressed strong interest in RAD's ability to automate perimeter patrols, improve visitor access control, and streamline monitoring operations through AI-driven systems.
Government & Scientific Institutions: Organizations overseeing critical infrastructure and space operations identified RAD's autonomous units as effective tools for safeguarding high-value assets and enhancing situational awareness.
Healthcare Networks: Several leading healthcare systems prioritized RAD's solutions for securing hospital exteriors and parking areas, with urgent deployment requests for ROAMEO, RIO and RAD Light My Way™.
Logistics & Transportation: Major providers initiated RFP discussions focused on modernizing entry and exit operations, aiming to reduce reliance on manned guard stations by deploying RAD's integrated platforms.
Retail & Commercial Properties: Large retail chains outlined plans to replace parking lot guards with autonomous patrol units, citing RAD's effectiveness in enhancing deterrence and improving overall safety.
Aerospace & Defense: Operators of secure facilities and industrial campuses evaluated ROAMEO and RIO for deployment in perimeter and parking zone protection, recognizing the value of autonomous coverage in high-security environments.
Entertainment & Venues: Event venues and stadiums prioritized rapid integration of RAD solutions, including Security Operations Center (SOC) enhancements with SARA and active on-site deterrence using RIO and ROAMEO.
Market Trends Confirm RAD's Direction
Conversations throughout the event reinforced RAD's position at the forefront of security innovation, with recurring themes including:
Guard Force Reduction: Organizations are actively shifting toward automation to reduce dependency on traditional guard services and improve operational efficiency.
Parking & Perimeter Safety: Interest in ROAMEO and RIO continues to grow as organizations look to secure expansive, high-risk areas with solutions that offer consistent coverage and active deterrence.
AI-Driven Security Monitoring: Organizations are increasingly prioritizing real-time analytics and proactive, intelligent alerting as essential components of modern security strategies.
"Winning both our category and the overall Judges' Choice Award at ISC West is an extraordinary honor," said Steve Reinharz, CEO/CTO of AITX and RAD. "But what excites us even more is the overwhelming response from top-tier companies and institutions that see RAD as the future of security and automation."
AITX, through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the nearly $50 billion (US) security and guarding services industryi through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers these tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-R, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit www.aitx.ai, www.radsecurity.com, www.stevereinharz.com, www.radgroup.ai, www.raddog.ai, and www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price.
###
Steve Reinharz949-636-7060@SteveReinharz
________________________i https://www.ibisworld.com/united-states/market-research-reports/security-services-industry/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247532
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Meryllion Resources Announces Related Party Loan
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2025) - Meryllion Resources Corporation (CSE: MYR) ("Meryllion" or the "Company") wishes to announce that it has entered into a loan agreement providing for a loan in the aggregate principal amount of CAD$195,000 (the "Loan") from Mr. David Steinepreis, a director of the Company. The Loan (i) is unsecured; (ii) has a term of 12 months; and (iii) bears interest at the rate of 6% per annum (said interest to be payable on a quarterly basis). The Company may prepay the Loan at any time, or from time to time, without penalty. The proceeds of the Loan will be used to pay certain accrued liabilities and for working capital purposes. The Loan is a related party transaction pursuant to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). With respect to the Loan, the Company has relied on the exemption from the valuation requirement pursuant to Section 5.5(b) (issuer not listed on specified markets) of MI 61-101 and from the minority shareholder approval requirement prescribed by Section 5.7(1)(a) (fair market value not more than 25% of market capitalization) of MI 61-101. For further information, please contact: Mr. Richard RevelinsDirector and Chief Executive OfficerMeryllion Resources Corporation +1-310-405-4475rrevelins@ Forward-Looking Statements Information set forth in this news release may involve forward-looking statements under applicable securities laws. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
TurnOnGreen Expands Contract Portfolio with $7.5 Million Backlog
Mission-Critical Mobile Communications UPS provided by Digital Power Corporation T2C2 (Transportable Tactical Command Communications) System Provided by Digital Power Corporation MILPITAS, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- TurnOnGreen, Inc. (OTC: TOGI) ('TurnOnGreen' or the 'Company'), together with its division Digital Power Corporation ('DPC'), a recognized leader in custom-engineered power solutions, announced that its contract backlog has grown to $7.5 million. This expanded backlog reflects strong demand for DPC's innovative, mission-critical power systems across multiple industries, including military and defense, industrial, medical, e-mobility, and telecommunications. The awarded contracts involve the design and production of advanced, ruggedized power systems engineered to perform reliably in extreme environments while meeting stringent operational requirements. TurnOnGreen and DPC specialize in custom, scalable solutions tailored to the unique needs of its global customer base. Their high-grade uninterruptible power supplies and integrated power platforms are deployed across diverse sectors, including land, sea, and airborne applications. These systems especially support essential military operations by meeting strict environmental and operational standards required by global defense OEMs. 'Digital Power's proven track record in delivering complex and bespoke power solutions is a testament to our commitment to technical innovation and customer satisfaction,' said Amos Kohn, Chairman and CEO of TurnOnGreen. 'This growing backlog not only reflects the trust our customers place in us, but also reinforces our dedication to consistently meet demanding specifications, tight timelines, and budget requirements across diverse industries and market sectors.' About TurnOnGreen TurnOnGreen Inc. (OTC:TOGI) designs and manufactures innovative, high-performance power solutions for mission-critical applications in some of the world's most demanding environments. Serving diverse industries, including defense and aerospace, medical and healthcare, industrial, telecommunications, and e-Mobility, TurnOnGreen seeks to deliver cutting-edge, reliable power technologies tailored to meet complex operational needs. With over 50 years of expertise, TurnOnGreen leverages decades of experience to develop customer-driven solutions that drive innovation and efficiency. The company collaborates closely with clients to engineer advanced products that enhance performance, sustainability, and reliability across multiple sectors. TurnOnGreen is headquartered in Milpitas, CA. For more information, visit Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'believes,' 'plans,' 'anticipates,' 'projects,' 'estimates,' 'expects,' 'intends,' 'strategy,' 'future,' 'opportunity,' 'may,' 'will,' 'should,' 'could,' 'potential,' or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors including a change in future projected revenue due to modification or cancellation of orders. More information, including potential risk factors, that could affect the Company's business and financial results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at and on the Company's website at TurnOnGreen Investor Contact:IR@ or (877) 634-0982 Photos accompanying this announcement are available at: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Tevard Biosciences Names Dr. Elisabeth Gardiner Chief Scientific Officer to Lead Next Phase of tRNA-Based Therapies
Boston, Massachusetts--(Newsfile Corp. - June 10, 2025) - Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the appointment of Elisabeth Gardiner, Ph.D., as Chief Scientific Officer. With more than 25 years of leadership in drug discovery and development across the biotech and pharmaceutical sectors, Dr. Gardiner brings deep translational expertise that will accelerate Tevard's mission to develop effective and durable tRNA-based therapies targeting the root cause of disease. As CSO, she will lead scientific strategy and R&D operations to expand Tevard's novel platform of engineered suppressor tRNAs, which recently demonstrated the first sustained restoration of full-length dystrophin in a Duchenne Muscular Dystrophy (DMD) model. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Dr. Gardiner's experience scaling discovery and translational programs will be critical as Tevard advances their lead program toward the clinic and expands their pipeline across additional indications. Tevard Biosciences is working to unlock the potential of tRNA-based therapies. The company's programs are based on its novel Suppressor tRNA technology platform that uses a viral vector to insert the normal amino acid at the site of the premature stop codon. Tevard's lead program targeting TTN-related dilated cardiomyopathy is advancing rapidly, with new data expected in the near future. Click image above to view full announcement. About Tevard Biosciences Tevard Biosciences is pioneering tRNA-based and other mRNA-modulating therapies to cure a broad range of genetic diseases. The privately held biotechnology company was founded by renowned scientists along with life science executives and entrepreneurs who are also fathers of children with rare diseases. Tevard is advancing the use of its novel suppressor tRNA platform in heart disease, muscular dystrophies, and neurological disorders. For more information, please visit Contacts: Michelle Linn michelle@ Source: Tevard To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
